Hepatic Xenetix-CT Perfusion
NCT01639703
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
96
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
Xenetix-CT perfusion imaging
Sponsor
Guerbet